NaturalAntibody

NaturalAntibody develops proprietary artificial intelligence software available in the form of a product ‘Antibody Discovery Platform.’ This product aims to analyze and engineer antibodies that may serve as candidates for new drugs (biotherapeutics). The platform operates solely through computer-based methods, known as in silico. The product consists of the ‘Antibody Database’ and analytical modules (containing AI-based models and bioinformatics tools).